Augmenting the research portfolio and elevating its prominence through enhanced quality and impact.
These facilities offer a wide range of services, including cutting-edge technologies and high-end instrumentation coupled with technical support for research.
Coronavirus (COVID-19) Update: SMHS Research Re-Start PlansVisit GW SMHS ON CAMPUS Policies and Guidelines website
The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science. The results show critical new insights into their novel vaccine strategy, which involves a stepwise approach to producing antibodies capable of targeting a wide range of HIV variants.
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of their lives. Now, a new study in Cell Reports explains why chronic inflammation may be happening and how suppression or even eradication of HIV in the body may not resolve it.
The Department of Dermatology at the George Washington University School of Medicine and Health Sciences received two awards from dermatology company Galderma to establish a research fund and a medical student research fellowship.
